Pharma channel feed – Endpoints News

Pharma channel feed

Belgian regulator recommends blocking Indian drugmaker's API production

3 months ago

Bristol Myers prunes pipeline amid new round of cost cuts

3 months ago

Updated: Hospital group blasts proposed 340B rebate models, requests to join lawsuits with HHS

3 months ago

AstraZeneca takes $753M charge on abandoned complement drug from Alexion deal

3 months ago

J&J, Intra-Cellular quickly sealed $14B deal as three others passed on buying the neuro drugmaker

3 months ago

Pfizer hires Novartis oncology exec to steer its cancer ambitions

3 months ago

AstraZeneca offers some detail on China probe, reaffirms commitment to that market

3 months ago

Updated: Lilly posts 45% sales jump, culls four programs across obesity, Alzheimer's, heart failure and eczema

3 months ago

Bristol Myers launches fresh round of major cost cuts in bid to get ahead of patent cliff

3 months ago

Novo Nordisk is feeling the competition from compounded GLP-1s, exec says

3 months ago

Revance and Crown are almost ready to close their deal after earlier bidding war

3 months ago

EyePoint shares more mid-stage data for therapy trying to compete with Regeneron's Eylea

3 months ago

GSK defiant against vaccine challenges, will prioritize other growth areas

3 months ago

Updated: Novo Nordisk sees growth slowing this year, plans CagriSema filing for 2026

3 months ago

Amgen announces hold on Phase 1 obesity candidate, pipeline cuts

3 months ago

J&J asks court for quick decision in 340B rebate model fight

3 months ago

Pfizer says it has at least $10B available for deals in 2025, with a focus on pipeline

3 months ago

Merck CEO says he’s confident in growth despite Gardasil ‘headwind’

3 months ago

Illumina added to China's blacklist following Biosecure Act, tariffs

3 months ago

FDA approves Supernus’ Parkinson’s drug-device after two rejections

3 months ago

Bavarian Nordic’s stock sinks after 2024 revenues underwhelm

3 months ago

Updated: Pfizer sticks to 2025 projections as Covid sales stabilize, R&D revamp continues

3 months ago

Regeneron will start delivering quarterly dividends 37 years into its existence

3 months ago

Astellas shakes up management despite impressive nine-month earnings

3 months ago

First page Previous page 14 15 161718 19 20 Next page Last page